Logo image of ALMCE.PA

MON COURTIER ENERGIE GROUPE (ALMCE.PA) Stock Fundamental Analysis

EPA:ALMCE - Euronext Paris - Matif - FR001400H3A0 - Common Stock - Currency: EUR

5.85  +0.2 (+3.54%)

Fundamental Rating

4

Overall ALMCE gets a fundamental rating of 4 out of 10. We evaluated ALMCE against 19 industry peers in the Independent Power and Renewable Electricity Producers industry. The financial health of ALMCE is average, but there are quite some concerns on its profitability. While showing a medium growth rate, ALMCE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALMCE has reported negative net income.
ALMCE had a positive operating cash flow in the past year.
ALMCE.PA Yearly Net Income VS EBIT VS OCF VS FCFALMCE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 1M 2M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.97%, ALMCE is doing worse than 78.95% of the companies in the same industry.
With a Return On Equity value of -2.03%, ALMCE is not doing good in the industry: 78.95% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -0.97%
ROE -2.03%
ROIC N/A
ROA(3y)8.1%
ROA(5y)N/A
ROE(3y)15.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALMCE.PA Yearly ROA, ROE, ROICALMCE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

ALMCE has a Gross Margin (23.71%) which is in line with its industry peers.
In the last couple of years the Gross Margin of ALMCE has declined.
The Profit Margin and Operating Margin are not available for ALMCE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.26%
GM growth 5YN/A
ALMCE.PA Yearly Profit, Operating, Gross MarginsALMCE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 20 30

More info and screens

6

2. Health

2.1 Basic Checks

ALMCE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALMCE has about the same amount of shares outstanding.
Compared to 1 year ago, ALMCE has a worse debt to assets ratio.
ALMCE.PA Yearly Shares OutstandingALMCE.PA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 1M 2M 3M
ALMCE.PA Yearly Total Debt VS Total AssetsALMCE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

ALMCE has an Altman-Z score of 2.82. This is not the best score and indicates that ALMCE is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of ALMCE (2.82) is better than 73.68% of its industry peers.
The Debt to FCF ratio of ALMCE is 2.76, which is a good value as it means it would take ALMCE, 2.76 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 2.76, ALMCE belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
ALMCE has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.00, ALMCE belongs to the best of the industry, outperforming 94.74% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 2.76
Altman-Z 2.82
ROIC/WACCN/A
WACC7.77%
ALMCE.PA Yearly LT Debt VS Equity VS FCFALMCE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M 4M 6M 8M 10M

2.3 Liquidity

A Current Ratio of 1.72 indicates that ALMCE should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.72, ALMCE is doing good in the industry, outperforming 73.68% of the companies in the same industry.
A Quick Ratio of 1.72 indicates that ALMCE should not have too much problems paying its short term obligations.
ALMCE has a Quick ratio of 1.72. This is in the better half of the industry: ALMCE outperforms 73.68% of its industry peers.
Industry RankSector Rank
Current Ratio 1.72
Quick Ratio 1.72
ALMCE.PA Yearly Current Assets VS Current LiabilitesALMCE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for ALMCE have decreased strongly by -115.63% in the last year.
Looking at the last year, ALMCE shows a quite strong growth in Revenue. The Revenue has grown by 17.25% in the last year.
The Revenue has been growing by 36.13% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-115.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-87.4%
Revenue 1Y (TTM)17.25%
Revenue growth 3Y36.13%
Revenue growth 5YN/A
Sales Q2Q%21.26%

3.2 Future

ALMCE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 77.28% yearly.
The Revenue is expected to grow by 12.21% on average over the next years. This is quite good.
EPS Next Y-50%
EPS Next 2Y77.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year14.98%
Revenue Next 2Y14.88%
Revenue Next 3Y12.21%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ALMCE.PA Yearly Revenue VS EstimatesALMCE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
ALMCE.PA Yearly EPS VS EstimatesALMCE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0.1 0.2 0.3 0.4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

ALMCE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 81.14 indicates a quite expensive valuation of ALMCE.
ALMCE's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. ALMCE is more expensive than 68.42% of the companies in the same industry.
ALMCE's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 36.28.
Industry RankSector Rank
PE N/A
Fwd PE 81.14
ALMCE.PA Price Earnings VS Forward Price EarningsALMCE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALMCE is valued a bit more expensive than the industry average as 63.16% of the companies are valued more cheaply.
Based on the Price/Free Cash Flow ratio, ALMCE is valued a bit cheaper than the industry average as 68.42% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 69.74
EV/EBITDA 30.51
ALMCE.PA Per share dataALMCE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A more expensive valuation may be justified as ALMCE's earnings are expected to grow with 77.28% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y77.28%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALMCE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MON COURTIER ENERGIE GROUPE

EPA:ALMCE (8/5/2025, 7:00:00 PM)

5.85

+0.2 (+3.54%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.33%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap21.41M
Analysts84.44
Price Target6.63 (13.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.33
Dividend Growth(5Y)N/A
DP-600.49%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)5.58%
Revenue NY rev (3m)5.58%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 81.14
P/S 0.87
P/FCF 69.74
P/OCF 30.2
P/B 2.14
P/tB 2.92
EV/EBITDA 30.51
EPS(TTM)-0.06
EYN/A
EPS(NY)0.07
Fwd EY1.23%
FCF(TTM)0.08
FCFY1.43%
OCF(TTM)0.19
OCFY3.31%
SpS6.74
BVpS2.73
TBVpS2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.97%
ROE -2.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.71%
FCFM 1.24%
ROA(3y)8.1%
ROA(5y)N/A
ROE(3y)15.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.26%
GM growth 5YN/A
F-Score5
Asset Turnover1.18
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 2.76
Debt/EBITDA 0.01
Cap/Depr 80.72%
Cap/Sales 1.63%
Interest Coverage N/A
Cash Conversion 149.58%
Profit Quality N/A
Current Ratio 1.72
Quick Ratio 1.72
Altman-Z 2.82
F-Score5
WACC7.77%
ROIC/WACCN/A
Cap/Depr(3y)39.27%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.73%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-115.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-87.4%
EPS Next Y-50%
EPS Next 2Y77.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.25%
Revenue growth 3Y36.13%
Revenue growth 5YN/A
Sales Q2Q%21.26%
Revenue Next Year14.98%
Revenue Next 2Y14.88%
Revenue Next 3Y12.21%
Revenue Next 5YN/A
EBIT growth 1Y-101.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year60%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y149.84%
FCF growth 3Y-48.05%
FCF growth 5YN/A
OCF growth 1Y231.05%
OCF growth 3Y-31.54%
OCF growth 5YN/A